Our Breakthroughs
SickKids is dedicated to advancing research to improve and save lives. Supported by our generous community of donors, including those making unrestricted gifts, here are some highlights of groundbreaking research and discoveries over the past year.
Single Patient Gene Therapy Clinical Trial at SickKids Carves a Path for Precision Child Health
A SickKids team of doctors and researchers conducted a gene therapy clinical trial for a child with SPG50, one of the first examples of individualized genetic medicine.
Novel Machine Learning Algorithm Creates Atlas of Cancer with Potential as Universal Diagnostic Platform
A new platform developed at SickKids classifies every known major childhood cancer, allowing physicians and researchers to identify specific cancer types faster and more accurately.
World first: Sunnybrook and SickKids Clinical Trial Delivers Chemotherapy to a hard-to-treat Paediatric Brain Tumour Using MRI-guided focused ultrasound.
The first paediatric patient recently successfully underwent the procedure as part of a safety and feasibility clinical trial in children with terminal paediatric brain tumours.
Photo credit: Kevin Van Paassen, Sunnybrook Health Sciences Centre.
Screening tool could help primary caregivers predict asthma risk early.
A team of researchers has developed a symptom-based screening tool that detects asthma risk in children as young as two years of age.
Precision magnetics could be game-changer for therapy-resistant brain cancers
New mechanical nanosurgery approach developed by SickKids and U of T researchers uses nanotechnology and precision magnetics to destroy tumour cells.